Literature DB >> 25750254

Age-Dependent Long-Term Potentiation Deficits in the Prefrontal Cortex of the Fmr1 Knockout Mouse Model of Fragile X Syndrome.

Henry G S Martin1,2,3, Olivier Lassalle1,2,3, Jonathan T Brown4, Olivier J Manzoni1,2,3.   

Abstract

The most common inherited monogenetic cause of intellectual disability is Fragile X syndrome (FXS). The clinical symptoms of FXS evolve with age during adulthood; however, neurophysiological data exploring this phenomenon are limited. The Fmr1 knockout (Fmr1KO) mouse models FXS, but studies in these mice of prefrontal cortex (PFC) function are underrepresented, and aging linked data are absent. We studied synaptic physiology and activity-dependent synaptic plasticity in the medial PFC of Fmr1KO mice from 2 to 12 months. In young adult Fmr1KO mice, NMDA receptor (NMDAR)-mediated long-term potentiation (LTP) is intact; however, in 12-month-old mice this LTP is impaired. In parallel, there was an increase in the AMPAR/NMDAR ratio and a concomitant decrease of synaptic NMDAR currents in 12-month-old Fmr1KO mice. We found that acute pharmacological blockade of mGlu5 receptor in 12-month-old Fmr1KO mice restored a normal AMPAR/NMDAR ratio and LTP. Taken together, the data reveal an age-dependent deficit in LTP in Fmr1KO mice, which may correlate to some of the complex age-related deficits in FXS.
© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Fragile X; LTP; NMDA receptor; mGlu receptor; synaptic plasticity

Mesh:

Substances:

Year:  2015        PMID: 25750254     DOI: 10.1093/cercor/bhv031

Source DB:  PubMed          Journal:  Cereb Cortex        ISSN: 1047-3211            Impact factor:   5.357


  20 in total

Review 1.  Pharmacotherapy for Fragile X Syndrome: Progress to Date.

Authors:  Matthew H Davenport; Tori L Schaefer; Katherine J Friedmann; Sarah E Fitzpatrick; Craig A Erickson
Journal:  Drugs       Date:  2016-03       Impact factor: 9.546

2.  Increased transient Na+ conductance and action potential output in layer 2/3 prefrontal cortex neurons of the fmr1-/y mouse.

Authors:  Brandy N Routh; Rahul K Rathour; Michael E Baumgardner; Brian E Kalmbach; Daniel Johnston; Darrin H Brager
Journal:  J Physiol       Date:  2017-05-23       Impact factor: 5.182

Review 3.  Medial prefrontal cortex in neurological diseases.

Authors:  Pan Xu; Ai Chen; Yipeng Li; Xuezhi Xing; Hui Lu
Journal:  Physiol Genomics       Date:  2019-08-02       Impact factor: 3.107

4.  Targeting Gamma-Related Pathophysiology in Autism Spectrum Disorder Using Transcranial Electrical Stimulation: Opportunities and Challenges.

Authors:  Fae B Kayarian; Ali Jannati; Alexander Rotenberg; Emiliano Santarnecchi
Journal:  Autism Res       Date:  2020-05-28       Impact factor: 5.216

5.  Dysregulated NMDA-Receptor Signaling Inhibits Long-Term Depression in a Mouse Model of Fragile X Syndrome.

Authors:  Anna Karina Hugger Toft; Camilla Johanne Lundbye; Tue G Banke
Journal:  J Neurosci       Date:  2016-09-21       Impact factor: 6.167

6.  Visual Experience-Dependent Oscillations and Underlying Circuit Connectivity Changes Are Impaired in Fmr1 KO Mice.

Authors:  Samuel T Kissinger; Qiuyu Wu; Christopher J Quinn; Adam K Anderson; Alexandr Pak; Alexander A Chubykin
Journal:  Cell Rep       Date:  2020-04-07       Impact factor: 9.423

Review 7.  Positive allosteric modulation of M1 and M4 muscarinic receptors as potential therapeutic treatments for schizophrenia.

Authors:  Samantha E Yohn; P Jeffrey Conn
Journal:  Neuropharmacology       Date:  2017-09-09       Impact factor: 5.250

8.  Sustained correction of associative learning deficits after brief, early treatment in a rat model of Fragile X Syndrome.

Authors:  Antonis Asiminas; Adam D Jackson; Susana R Louros; Sally M Till; Teresa Spano; Owen Dando; Mark F Bear; Sumantra Chattarji; Giles E Hardingham; Emily K Osterweil; David J A Wyllie; Emma R Wood; Peter C Kind
Journal:  Sci Transl Med       Date:  2019-05-29       Impact factor: 17.956

9.  Reelin-Haploinsufficiency Disrupts the Developmental Trajectory of the E/I Balance in the Prefrontal Cortex.

Authors:  Lamine Bouamrane; Andrew F Scheyer; Olivier Lassalle; Jillian Iafrati; Aurore Thomazeau; Pascale Chavis
Journal:  Front Cell Neurosci       Date:  2017-01-12       Impact factor: 5.505

10.  Endocannabinoids Mediate Muscarinic Acetylcholine Receptor-Dependent Long-Term Depression in the Adult Medial Prefrontal Cortex.

Authors:  Henry G S Martin; Axel Bernabeu; Olivier Lassalle; Clément Bouille; Corinne Beurrier; Anne-Laure Pelissier-Alicot; Olivier J Manzoni
Journal:  Front Cell Neurosci       Date:  2015-12-01       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.